Literature DB >> 7263660

Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites.

L J Roberts, B J Sweetman, J A Oates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7263660

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  35 in total

Review 1.  Aspirin in patients with coronary artery disease: is it simply irresistible?

Authors:  G V Nair; C J Davis; M E McKenzie; D R Lowry; V L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

Review 2.  Antiplatelet drugs.

Authors:  Gustav Born; Carlo Patrono
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Suboptimal inhibition of platelet cyclooxygenase-1 by aspirin in metabolic syndrome.

Authors:  James P Smith; Elias V Haddad; Mary B Taylor; Denise Oram; Dana Blakemore; Qingxia Chen; Olivier Boutaud; John A Oates
Journal:  Hypertension       Date:  2012-02-06       Impact factor: 10.190

Review 4.  Current concepts for a drug-induced inhibition of formation and action of thromboxane A2.

Authors:  H Patscheke
Journal:  Blut       Date:  1990-05

Review 5.  The Jeremiah Metzger lecture. Participation of eicosanoids in the syndromes of myocardial ischemia.

Authors:  J A Oates
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

6.  Effect of dexamethasone on in vivo prostanoid production in the rabbit.

Authors:  A Náray-Fejes-Tóth; G Fejes-Tóth; C Fischer; J C Frölich
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

7.  In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.

Authors:  P Henriksson; A Wennmalm; O Edhag; O Vesterqvist; K Green
Journal:  Br Heart J       Date:  1986-06

8.  Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk.

Authors:  M T Olson; T S Kickler; J A Lawson; R C McLean; J Jani; G A FitzGerald; J J Rade
Journal:  J Thromb Haemost       Date:  2012-12       Impact factor: 5.824

9.  Systemic lysis protects against the effects of platelet activation during coronary thrombolysis.

Authors:  D J Fitzgerald; M Hanson; G A FitzGerald
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1.

Authors:  P S Ward; R W Fuller; J M Ritter; S J Cashman; A J Rees; C T Dollery
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.